Effects of FGF-2 and IGF-1 on Adult Canine Articular Chondrocytes in Type II Collagen-glycosaminoglycan Scaffolds in Vitro
Overview
Rheumatology
Authors
Affiliations
Objective: Chondrocyte-seeded tissue engineering scaffolds hold the promise of enhancing certain cartilage repair procedures. The objective of this study was to evaluate the effects of selected growth factors [fibroblast growth factor (FGF)-2 and insulin-like growth factor (IGF)-1] individually and in combination on adult canine articular chondrocyte-seeded type II collagen-glycosaminoglycan (GAG) scaffolds grown in serum-free (SF) medium.
Design: Approximately 500,000 second passage chondrocytes were seeded into discs of the scaffold, 4mm diameterx2 mm thick. The constructs were grown in the following media: serum-containing medium; a basal SF medium; SF with 5 ng/ml FGF-2; SF with 25 ng/ml FGF-2; SF with 100 ng/ml IGF-1; and SF with 5 ng/ml FGF-2 plus 100 ng/ml IGF-1. The DNA and GAG contents of the scaffolds were determined after 1 day and 2 weeks and the protein and GAG synthesis rates determined at 2 weeks using radiolabels. Histology and type II collagen immunohistochemistry were also performed.
Results: FGF-2 at 5 ng/ml was found to substantially increase the biosynthetic activity of the cells and the accumulation of GAG. The histology demonstrated chondrocytes uniformly distributed through a matrix that stained intensely for GAG and type II collagen after only 2 weeks. Of interest were the rapid degradation of the collagen scaffold, despite the fact that the scaffold was carbodiimide cross-linked, and the contraction of the constructs. There were less pronounced effects using the higher dose of FGF-2 and the combination with IGF-1.
Conclusions: Chondrocyte-seeded type II collagen scaffolds cultured in SF medium supplemented with 5 ng/ml FGF-2 undergo contraction, demonstrate an increase in construct incorporation of radiolabeled sulfate, and display qualitative signs of chondrogenesis.
Lara-Arias J, Pena-Martinez V, Rodriguez-Corpus L, Romero-Diaz V, Alvarez-Lozano E, Martinez-Rodriguez H Polymers (Basel). 2024; 16(14).
PMID: 39065286 PMC: 11281257. DOI: 10.3390/polym16141968.
Huang Y, Zhao H, Wang Y, Bi S, Zhou K, Li H Front Bioeng Biotechnol. 2023; 11:1089031.
PMID: 37811379 PMC: 10556751. DOI: 10.3389/fbioe.2023.1089031.
Collagen type II: From biosynthesis to advanced biomaterials for cartilage engineering.
Wu Z, Korntner S, Mullen A, Zeugolis D Biomater Biosyst. 2023; 4:100030.
PMID: 36824570 PMC: 9934443. DOI: 10.1016/j.bbiosy.2021.100030.
Jelodari S, Sadrabadi A, Zarei F, Jahangir S, Azami M, Sheykhhasan M Biomed Res Int. 2022; 2022:7638245.
PMID: 35118158 PMC: 8807044. DOI: 10.1155/2022/7638245.
Li Y, Fan Q, Jiang Y, Gong F, Xia H Exp Ther Med. 2017; 14(3):2657-2663.
PMID: 28962209 PMC: 5609294. DOI: 10.3892/etm.2017.4808.